Chesnara Plc: Fourth acquisition in two years
12 November 2026
Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector specializing in molecular diagnostics and precision medicine, presents a fascinating opportunity for investors navigating..
Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company situated in Dublin, Ireland, is garnering significant attention in the healthcare sector. Specializing in developing therapies for diseases..
Surmodics, Inc. (NASDAQ: SRDX), a prominent player in the healthcare sector, is making strategic strides within the medical device industry. Headquartered in Eden Prairie, Minnesota, the..
Septerna, Inc. (NASDAQ: SEPN) has been capturing the attention of investors with its significant upside potential, as reflected in the 113.28% potential gain suggested by the..
Verve Therapeutics, Inc. (NASDAQ: VERV), a trailblazer in the biotechnology sector, is carving a niche in the healthcare landscape with its innovative approach to treating cardiovascular..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is carving a niche in the biotechnology sector with its focus on addressing unmet medical needs for rare diseases. As a..
PureTech Health plc (LSE: PRTC), a prominent player in the biotechnology sector, is capturing attention with its impressive potential upside, making it an intriguing prospect for..
Rapport Therapeutics, Inc. (NASDAQ: RAPP), a burgeoning force in the biotechnology sector, has caught the attention of investors with its promising potential upside of 190.70%. This..
Valneva SE (NASDAQ: VALN), a French-based biotechnology company, is making waves in the healthcare sector with its innovative vaccine offerings targeting infectious diseases with unmet needs...
Theravance Biopharma, Inc. (NASDAQ: TBPH), a notable player in the biotechnology sector, is making waves with its promising pipeline and strategic collaborations. For investors with a..
Investors with a penchant for high-growth opportunities in the biotechnology sector might find Celcuity Inc. (NASDAQ: CELC) an intriguing prospect. With its current market cap standing..
For investors with an eye on the biotechnology sector, Humacyte, Inc. (HUMA) presents a compelling opportunity, particularly given its ambitious potential upside of 313.53%. This North..
Investors with an appetite for growth in the healthcare sector might find Zenas BioPharma, Inc. (NASDAQ: ZBIO) an intriguing prospect. With a market capitalization of $419.6..
Abivax SA (ABVX) is a name that stands out in the biotechnology sector, particularly for investors looking for high-growth potential. Headquartered in Paris, France, this clinical-stage..
Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, is currently trading at $6.99 per share, showcasing a potential upside of 93.13% based..
Standard BioTools Inc. (NASDAQ: LAB), headquartered in South San Francisco, California, is a prominent player in the healthcare sector, specifically within the medical devices industry. This..
MBX Biosciences, Inc. (NASDAQ: MBX), a promising player in the biotechnology sector, is drawing significant attention from investors, and for good reason. This clinical-stage biopharmaceutical company..
Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company, is making waves in the healthcare sector with its cutting-edge approach to drug development. Based in New Haven,..
Evolus, Inc. (NASDAQ: EOLS), a prominent name in the healthcare sector, particularly within the specialized field of drug manufacturing, is drawing significant attention from investors. The..
